Skip to main content
Glama

Stratalize Intelligence

get_payer_intelligence

Read-only

Use when benchmarking payer performance, building a denial management strategy, or preparing revenue cycle board reporting. Returns denial rates by payer, prior authorization burden by specialty, and payer mix commentary. Example: Commercial payer denial rates — UnitedHealth 8.2%, Cigna 9.4%, Aetna 7.1% — prior auth burden 34% higher for specialist services — top quartile denial rate is 5.1%. Source: Stratalize national revenue cycle composite. $0.10 USDC per call.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
specialtyNo
payer_nameNo

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

A3.9/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and destructiveHint=false, so the safety profile is covered. The description adds valuable context: the data source ('Stratalize national revenue cycle composite'), the per-call cost ($0.10 USDC), and an example of the output shape. These are not in the annotations and help an agent anticipate real-world behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the use cases, followed by the return payload, an illustrative example, source, and cost. Each sentence carries unique information; nothing is redundant. The only inefficiency is the long example, but it is illustrative rather than fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a read-only tool with two optional parameters and no output schema, the description provides a reasonable baseline: what it returns, when to use it, source, and cost. However, the parameter usage is a significant gap, and the lack of any note about filtering or output variability leaves an agent uncertain about customization. It's adequate but not fully complete for all calling scenarios.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters2/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, so the description must fully explain the parameters. It does not: 'specialty' and 'payer_name' are never described as filters. The example mentions payers and a specialty but does not explicitly state that these can be passed as inputs Labs. An agent would not know how to leverage the parameters to narrow results. The description fails to compensate for the missing schema descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb ('Returns') and resource ('denial rates by payer, prior authorization burden by specialty, and payer mix commentary'), clearly distinguishing it from generic data tools. The example output further pinpoints the nature of the data, making the tool's purpose unambiguous even among many sibling benchmarking tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly provides when-to-use contexts: 'when benchmarking payer performance, building a denial management strategy, or preparing revenue cycle board reporting.' It does not mention alternatives or when not to use, but the use cases are concrete and actionable enough for an agent to select this tool appropriately.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources